BIO vs NOMA · rev $651.0M vs rev $6.4K
BIO (BIO) versus NOMADAR Corp. Class A Common Stock (NOMA) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
NOMADAR Corp. Class A Common Stock (NOMA) is a leisure company listed on NASDAQ.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported NOMA revenue for 2025-12-31 was $6.4K. Net income was -$2.8M. Revenue was down 20.5% from 2024-12-31 to 2025-12-31. NOMA currently screens at market cap $58.4M.
BIO currently screens at market cap $0. NOMA currently screens at market cap $58.4M.
Not investment advice. Open the BIO and NOMA stock pages for the full models.
Not investment advice.